Related Content
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Medication adherence could be blockbuster for specialty
- Walgreens launches high-impact push in support of World AIDS Day campaign
- Moving PSE to Rx-only in Mo. lacks fiscal sense
NEW YORK — Slated to hit the U.S. retail market in April is the new Neovadiol range from Vichy Laboratoires, a leading pharmacy skin care line for the signs of hormonal aging in Europe and Canada.
The new Neovadiol Gf Lip & Eye Contours and Neovadiol Lumiere BB Cream complete the range, which already includes day and night creams. The Neovadiol range was developed in consultation with experts like dermatologists, obstetricians, gynecologists and psychologists.
Women over the age of 50 represent 43% of the adult population in the United States and 75% of the nation’s wealth, the company stated. However, skin care lines that target this consumer represent less than 10% of the overall skin care market.
The Neovadiol range now includes Neovadiol Gf Day and Night Cream ($55) and the new Neovadiol Gf Eyes & Lips Contours ($47) and the new Neovadiol Lumiere BB Cream ($42).
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
